For example, Jain et al. coated docetaxel-loaded liposomes with ligands that bind specifically to vascular endothelial growth factor 2 receptors (VEGFR-2), a key angiogenic factor which is commonly upregulated in new peritumoral blood vessels, in breast cancer therapy [156]. The gene discussed is KDR; the disease is breast cancer.